|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Consecutive versus separate sessions of endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) for symptomatic choledocholithiasis显示文摘 | Fabiana Benjaminov Assaf Stein George Lichtman Itamar Pomeranz Fred M. Konikoff | 2013 | Surgical Endoscopy2013，，6： | 2 |
| 2 | Potential of Blood Eosinophils, Eosinophil-Derived Neurotoxin, and Eotaxin-3 as Biomarkers of Eosinophilic Esophagitis显示文摘 | Michael R. Konikoff Carine Blanchard Cassie Kirby Bridget K. Buckmeier Mitchell B. Cohen James E. Heubi Philip E. Putnam Marc E. Rothenberg | 2006 | Clinical Gastroenterology and Hepatology2006，，： | 1 |
| 3 | A phase -2, random- ized, double blind, placebo -controlled trial of aramchol for the treatment of nonalcoholic fatty liver disease (NAFLD) 显示文摘 | SAFADI R KONIKOFF FM OREN R | 2012 | J Hepatology2012，56，： | 1 |
| 4 | A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate for Pediatric Eosinophilic Esophagitis显示文摘 | Michael R. Konikoff Richard J. Noel Carine Blanchard Cassie Kirby Sean C. Jameson Bridget K. Buckmeier Rachel Akers Mitchell B. Cohen Margaret H. Collins Amal H. Assa’ad Seema S. Aceves Philip E. Putnam Marc E. Rothenberg | 2006 | Gastroenterology2006，，： | 1 |
| 5 | An angulated com-mon bile duct predisposes to recurrent symptomatic bileduct stones after endoscopic stone extraction显示文摘 | Keizman D Shalom MI Konikoff FM | 2006 | Surg En-dosc2006，20，10： | 1 |
| 6 | Endoscopic sphinete- rotomy and tempo:'ary internal stenting for bile leaks following complex hepatic trauma 显示文摘 | Lubezky N Konikoff FM Rosin D | 2006 | Br J Surg2006，93，： | 1 |
| 7 | Gallstones-approach to medical management 显示文摘 | Konikoff FM | 2003 | Med Gen Med2003，5，4： | 1 |
| 8 | Hypocholesterolemic effects of fatty acid bile acid conjugates (FABACs) in mice 显示文摘 | Leikin-Frenkel A Parini P Konikoff FM | 2008 | Arch Biochem Biophys2008，471，1： | 1 |
| 9 | Estimation of HIV incidence using multiple biomarkers显示文摘 | Brookmeyer R Konikoff J Laeyendecker O | | 0，，03： | 1 |
| 10 | Role of fecal calprotectin as a biomar- ker of intestinal inflammation in inflammatory bowel disease 显示文摘 | Konikoff MR Denson LA | 2006 | Inflamm Bowel Dis2006，12，6： | 1 |
| 11 | Clinicalcrown length of the maxillary anterior teeth preorthodon-tics and postorthodontics 显示文摘 | Konikoff BM Johnson DC Schenkein HA | 2007 | J Periodontol2007，78，4： | 1 |
| 12 | Very early feeding in stable small for gestational age preterm infants: a randomized clinical trial显示文摘 | Amon S Sulam D Konikoff F | 2013 | J Pediatr (RioJ)2013，89，4： | 1 |
| 13 | The effects of short term lipid infusion on plasma and hepatic bile lipids in humans显示文摘 | Konikoff FM Moster AM | 1999 | Gut1999，45，3： | 1 |
| 14 | A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis 显示文摘 | Konikoff MR Noel R J Blanehard C | 2006 | Gastroenterology2006，131，： | 1 |
| 15 | CT findings of latrogenic compli- cations following gastrointestinal endoluminal procedures显示文摘 | Zissin R Konikoff F Gayer G | 2006 | Se- min Ultrasound CT MR2006，27，12： | 1 |
| 16 | Potential of blood eosinoahils, eosinonhil-derived neurotoxin, and eotaxin-3 asbiomarkersof eosinophilic esophagitis 显示文摘 | Konikoff MR Blanchard C Kirby C | 2006 | Clin Gastroenterol Hepatol2006，4，11： | 1 |
| 17 | Role of fecal calprotectin as a biomarker of intestinal inflammation in inflam-matory bowel disease显示文摘 | Konikoff MR Denson LA | | 0，，06： | 1 |
| 18 | Endoscopic sphincterotomy and temporary internal stenting for bile leaks following complex hepatic trauma显示文摘 | Lubezky N Konikoff FM Rosin D | 2006 | Br J Surg2006，93，： | 1 |
| 19 | Effect of ezetimibe on the prevalence of cholelithiasis显示文摘AIM:To investigate the prevalence of cholelithiasis among patients treated with ezetimibe.METHODS:A retrospective,case-control study based on computerized medical records from patients of the Clalit Health Services,Sharon-Shomron region,from 2000 to 2009.Patients 20-85 years of age,who had been treated with ezetimibe and statins or statins only for at least 6 mo,and who had an abdominal ultrasound were included in the study.Collected data included age,gender,ezetimibe treatment duration,presence of hypothyroidism or diabetes,and existence of cholelithiasis as determined by ultrasound.Excluded were subjects after gallbladder resection,with hemolysis,myeloproliferative or inflammatory bowel diseases,and those treated with ursodeoxycholic acid and fibrates.Patients treated with statins and ezetimibe(study group) were compared to patients treated with statins only(control group).RESULTS:The study group included 25 patients and the control group 168.All patients in the study were treated with statins.The study group included 13 males(52%) and 12 females(48%),the control group 76 males(45%) and 92(55%) females(P = 0.544).The groups did not differ in age(mean age:68 ± 8 years,range 53-85 years vs mean age:71 ± 8 years,range 51-85 years;P = 0.153) or in the rate of diabetic and hypothyroid patients [11(44%) vs 57(33%),P = 0.347 in the study group and 5(20%) vs 23(14%),P = 0.449 in the control group,respectively].Patients in the study group were treated with ezetimibe for an average of 798 ± 379 d.Cholelithiasis was found in 4(16%) patients in the study group and in 33(20%) patients in the control group(P = 0.666).CONCLUSION:Ezetimibe does not appear to influence the prevalence of gallstones. | Assaf Stein Doron Hermoni Avishay Elis Fred M Konikoff | 2012 | World Journal of Gastroenterology2012，18，40： | 1 |
| 20 | CT findings of latrogenic compli- cations following gastrointestinal endoluminal procedures 显示文摘 | Zissin R Konikoff F Gayer G | 2006 | Semin Ultrasound CT MR2006，27，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员